As an inhibitor of cyclooxygenase-2, the non-steroidal anti-inflammatory drug celecoxib was originally approved for the treatment of osteoarthritis and adult rheumatoid arthritis (immune system diseases). This evidence concerns the gene PTGS2 and rheumatoid arthritis.